Wednesday, May 12, 2021

What is behind the fall of Inovio Pharmaceuticals Inc. (INO) stock?

Inovio Pharmaceuticals Inc.‎ (INO), a biotechnology company that focuses on the discovery, development, and commercialization of precisely designed DNA medicines to treat and protect people from infectious diseases, announced its plan for phase 3 trial of its COVID-19 vaccine candidate, INO-4800. In accordance to the rapid production of various vaccines, the Defense Health Agency (DHA) along with the relevant authorities, will halt providing funds for phase 3 of the INNOVATE trials.  INO stock plummeted adjacent to the news.


5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored



At last check in premarket trading, shares of Inovio Pharmaceuticals Inc. (INO) declined 26.83% at $6.68.The stock of INO decreased 0.33% to complete the last trading session at $9.13. The price range of the company’s shares fluctuated between $8.92 and $9.37. In the past 12 months, the company’s stock has retreated -22.03%, and in the last week, the stock has moved up 1.33%

About INOVIO Trials.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


INOVIO’s strategic relationships with Advaccine and the International Vaccine Institute is aiming for a global phase 3 trial, established on safety and immunogenicity data generated from the phase 2 studies. INOVIO will continue the evaluation of its vaccine, focusing to protect against mutated variants of covid 19.

INOVIO’s DNA vaccine, better known as, INO-4800 focuses against SARS-CoV-2, which causes covid-19. INOVIO provides a large number of trials and experience in working with coronaviruses and has pioneered to start a Phase 2a trial for INO-4700, which is a vaccine for a coronavirus that causes Middle East Respiratory Syndrome (MERS). The vaccine is administered directly into the cells to cause an immune response and provide resistance.

NO-4800 is the only nucleic-acid based vaccine that can be safely kept at room temperature (37C) for more than 12 months and consists of a shelf life of 5 years. Furthermore, it does not require to be frozen during transport, which is a hefty consideration in regards to public immunization.

INOVIO presently has 15 DNA medicine clinical programs specializing in HPV-associated diseases, cancer, and infectious diseases, focusing especially on MERS and COVID-19 diseases which is being developed under funding from the Coalition for Epidemic Preparedness Innovations (CEPI) and the U.S. Department of Defense.

Conclusion

An accumulated total of 3,000 patients have been administered with INOVIO investigational DNA medicines in more than 7,000 applications across a range of broad clinical trials, which has increased investor expectations from the company. However, discontinuation of grants from DHA and the relevant authorities has slowed the clinical trials, due to which INO stock plummeted immensely.

Latest news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

Related news

What is behind the fall of Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock?

Torchlight Energy Resources, Inc. (NASDAQ: TRCH), a growth oil and gas exploration company specializing in the acquisition and development of highly profitable domestic oil...

Eros STX Global Corporation (ESGC) stock is declining: Here is the reason why?

Eros STX Global Corporation (NYSE ESGC) a global multinational media company that acquires, produces, and distributes films, television shows, and digital content issued its...

Yum China Holdings Inc. (YUMC): The Most Important Numbers You Should Know

Yum China Holdings Inc. (YUMC), which operates Taco Bell Restaurants, KFC Restaurants, and Pizza Hut Restaurants in China, has published its first-quarter report for...

Why shares of Akerna Corp. (KERN) stock are up today?

Akerna (KERN), a cannabis technology company focusing to connect data points in the global cannabis supply chain and developer of the cannabis industry's first...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.